Literature DB >> 27606322

Neuregulin 3 Knockout Mice Exhibit Behaviors Consistent with Psychotic Disorders.

Lindsay N Hayes1, Alexey Shevelkin1, Mariela Zeledon2, Gary Steel3, Pei-Lung Chen4, Cassandra Obie3, Ann Pulver5, Dimitrios Avramopoulos5, David Valle3, Akira Sawa6, Mikhail V Pletnikov7.   

Abstract

Neuregulin 3 (NRG3) is a paralog of NRG1. Genetic studies in schizophrenia demonstrate that risk variants in NRG3 are associated with cognitive and psychotic symptom severity, and several intronic single nucleotide polymorphisms in NRG3 are associated with delusions in patients with schizophrenia. In order to gain insights into the biological function of the gene, we generated a novel Nrg3 knockout (KO) mouse model and tested for neurobehavioral phenotypes relevant to psychotic disorders. KO mice displayed novelty-induced hyperactivity, impaired prepulse inhibition of the acoustic startle response, and deficient fear conditioning. No gross cytoarchitectonic or layer abnormalities were noted in the brain of KO mice. Our findings suggest that deletion of the Nrg3 gene leads to alterations consistent with aspects of schizophrenia. We propose that KO mice will provide a valuable animal model to determine the role of the NRG3 in the molecular pathogenesis of schizophrenia and other psychotic disorders.

Entities:  

Keywords:  Fear conditioning; Hyperactivity; Neuregulin 3; Prepulse inhibition; Psychotic disorders

Year:  2016        PMID: 27606322      PMCID: PMC4996025          DOI: 10.1159/000445836

Source DB:  PubMed          Journal:  Mol Neuropsychiatry        ISSN: 2296-9179


  55 in total

1.  Identification of a Pax6-dependent epidermal growth factor family signaling source at the lateral edge of the embryonic cerebral cortex.

Authors:  Stavroula Assimacopoulos; Elizabeth A Grove; Clifton W Ragsdale
Journal:  J Neurosci       Date:  2003-07-23       Impact factor: 6.167

2.  The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders.

Authors:  Alon Shamir; Oh-Bin Kwon; Irina Karavanova; Detlef Vullhorst; Elias Leiva-Salcedo; Megan J Janssen; Andres Buonanno
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

Review 3.  Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour.

Authors:  Colm M P O'Tuathaigh; Daniela Babovic; Gillian O'Meara; Jeremiah J Clifford; David T Croke; John L Waddington
Journal:  Neurosci Biobehav Rev       Date:  2006-06-19       Impact factor: 8.989

4.  Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology.

Authors:  Bagrat Abazyan; Jun Nomura; Geetha Kannan; Koko Ishizuka; Kellie L Tamashiro; Frederick Nucifora; Vladimir Pogorelov; Bruce Ladenheim; Chunxia Yang; Irina N Krasnova; Jean Lud Cadet; Carlos Pardo; Susumu Mori; Atsushi Kamiya; Michael W Vogel; Akira Sawa; Christopher A Ross; Mikhail V Pletnikov
Journal:  Biol Psychiatry       Date:  2010-12-15       Impact factor: 13.382

5.  Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons.

Authors:  Lei Wen; Yi-Sheng Lu; Xin-Hong Zhu; Xiao-Ming Li; Ran-Sook Woo; Yong-Jun Chen; Dong-Min Yin; Cary Lai; Alvin V Terry; Almira Vazdarjanova; Wen-Cheng Xiong; Lin Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-29       Impact factor: 11.205

6.  Extinction memory is impaired in schizophrenia.

Authors:  Daphne J Holt; Kelimer Lebron-Milad; Mohammed R Milad; Scott L Rauch; Roger K Pitman; Scott P Orr; Brittany S Cassidy; Jared P Walsh; Donald C Goff
Journal:  Biol Psychiatry       Date:  2008-11-04       Impact factor: 13.382

7.  Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1.

Authors:  C M P O'Tuathaigh; D Babovic; G J O'Sullivan; J J Clifford; O Tighe; D T Croke; R Harvey; J L Waddington
Journal:  Neuroscience       Date:  2007-05-21       Impact factor: 3.590

8.  Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system.

Authors:  Claudia S Barros; Barbara Calabrese; Pablo Chamero; Amanda J Roberts; Ed Korzus; Kent Lloyd; Lisa Stowers; Mark Mayford; Shelley Halpain; Ulrich Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-24       Impact factor: 11.205

9.  Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse.

Authors:  Mari S Golub; Stacey L Germann; K C Kent Lloyd
Journal:  Behav Brain Res       Date:  2004-08-12       Impact factor: 3.332

10.  Phenotypic characterization of transgenic mice overexpressing neuregulin-1.

Authors:  Taisuke Kato; Atsushi Kasai; Makoto Mizuno; Liang Fengyi; Norihito Shintani; Sadaaki Maeda; Minesuke Yokoyama; Miwako Ozaki; Hiroyuki Nawa
Journal:  PLoS One       Date:  2010-12-09       Impact factor: 3.240

View more
  18 in total

1.  Controlling of glutamate release by neuregulin3 via inhibiting the assembly of the SNARE complex.

Authors:  Ya-Nan Wang; Dwight Figueiredo; Xiang-Dong Sun; Zhao-Qi Dong; Wen-Bing Chen; Wan-Peng Cui; Fang Liu; Hong-Sheng Wang; Hai-Wen Li; Heath Robinson; Er-Kang Fei; Bing-Xing Pan; Bao-Ming Li; Wen-Cheng Xiong; Lin Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

Review 2.  Neuregulin 3 and its roles in schizophrenia risk and presentation.

Authors:  Dimitrios Avramopoulos
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-05-29       Impact factor: 3.568

3.  Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study.

Authors:  Tiffany A Greenwood; Laura C Lazzeroni; Adam X Maihofer; Neal R Swerdlow; Monica E Calkins; Robert Freedman; Michael F Green; Gregory A Light; Caroline M Nievergelt; Keith H Nuechterlein; Allen D Radant; Larry J Siever; Jeremy M Silverman; William S Stone; Catherine A Sugar; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; Ruben C Gur; Raquel E Gur; David L Braff
Journal:  JAMA Psychiatry       Date:  2019-12-01       Impact factor: 21.596

4.  Transcytosis and trans-synaptic retention by postsynaptic ErbB4 underlie axonal accumulation of NRG3.

Authors:  Tanveer Ahmad; Detlef Vullhorst; Rituparna Chaudhuri; Carlos M Guardia; Nisha Chaudhary; Irina Karavanova; Juan S Bonifacino; Andres Buonanno
Journal:  J Cell Biol       Date:  2022-05-17       Impact factor: 8.077

5.  Developmental, neurochemical, and behavioral analyses of ErbB4 Cyt-1 knockout mice.

Authors:  Larissa Erben; Jacqueline P Welday; Marie E Cronin; Ricardo Murphy; Miguel Skirzewski; Detlef Vullhorst; Steven L Carroll; Andres Buonanno
Journal:  J Neurochem       Date:  2022-05-06       Impact factor: 5.546

6.  Structural Similarities between Neuregulin 1-3 Isoforms Determine Their Subcellular Distribution and Signaling Mode in Central Neurons.

Authors:  Detlef Vullhorst; Tanveer Ahmad; Irina Karavanova; Carolyn Keating; Andres Buonanno
Journal:  J Neurosci       Date:  2017-04-21       Impact factor: 6.167

Review 7.  Source and Impact of the EGF Family of Ligands on Intestinal Stem Cells.

Authors:  Helen E Abud; Wing Hei Chan; Thierry Jardé
Journal:  Front Cell Dev Biol       Date:  2021-07-19

8.  Gene expression patterns of chicken neuregulin 3 in association with copy number variation and frameshift deletion.

Authors:  Hideaki Abe; Daiki Aoya; Hiro-Aki Takeuchi; Miho Inoue-Murayama
Journal:  BMC Genet       Date:  2017-07-21       Impact factor: 2.797

9.  Neuregulins 1, 2, and 3 Promote Early Neurite Outgrowth in ErbB4-Expressing Cortical GABAergic Interneurons.

Authors:  Afrida Rahman-Enyart; Cary Lai; Anne L Prieto
Journal:  Mol Neurobiol       Date:  2020-06-16       Impact factor: 5.682

10.  ErbB4 signaling in dopaminergic axonal projections increases extracellular dopamine levels and regulates spatial/working memory behaviors.

Authors:  M Skirzewski; I Karavanova; A Shamir; L Erben; J Garcia-Olivares; J H Shin; D Vullhorst; V A Alvarez; S G Amara; A Buonanno
Journal:  Mol Psychiatry       Date:  2017-07-20       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.